The prospects of glycan biomarkers for the diagnosis of diseases

Carlito B Lebrilla, Hyun Joo An

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.

Original languageEnglish (US)
Pages (from-to)17-20
Number of pages4
JournalMolecular BioSystems
Volume5
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Polysaccharides
Biomarkers
Glycosylation
Disease Progression
Neoplasms

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Biology

Cite this

The prospects of glycan biomarkers for the diagnosis of diseases. / Lebrilla, Carlito B; An, Hyun Joo.

In: Molecular BioSystems, Vol. 5, No. 1, 2009, p. 17-20.

Research output: Contribution to journalArticle

Lebrilla, Carlito B ; An, Hyun Joo. / The prospects of glycan biomarkers for the diagnosis of diseases. In: Molecular BioSystems. 2009 ; Vol. 5, No. 1. pp. 17-20.
@article{c41d9f51622e4ab8b98767ba02b7269a,
title = "The prospects of glycan biomarkers for the diagnosis of diseases",
abstract = "Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.",
author = "Lebrilla, {Carlito B} and An, {Hyun Joo}",
year = "2009",
doi = "10.1039/b811781k",
language = "English (US)",
volume = "5",
pages = "17--20",
journal = "Molecular BioSystems",
issn = "1742-206X",
publisher = "Royal Society of Chemistry",
number = "1",

}

TY - JOUR

T1 - The prospects of glycan biomarkers for the diagnosis of diseases

AU - Lebrilla, Carlito B

AU - An, Hyun Joo

PY - 2009

Y1 - 2009

N2 - Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.

AB - Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.

UR - http://www.scopus.com/inward/record.url?scp=57449116570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57449116570&partnerID=8YFLogxK

U2 - 10.1039/b811781k

DO - 10.1039/b811781k

M3 - Article

C2 - 19081926

AN - SCOPUS:57449116570

VL - 5

SP - 17

EP - 20

JO - Molecular BioSystems

JF - Molecular BioSystems

SN - 1742-206X

IS - 1

ER -